Montelukast
Montelukast is a leukotriene receptor antagonist used in asthma research. It is widely applied in both in vivo and in vitro studies to investigate inflammatory pathways and has been associated with rare instances of drug-induced liver injury in clinical reports.
Product Specifications
CAS Number
158966-92-8
Product Name Alternative
Antioxidant, asthma, ALOX5, COVID-19, Cysltr1, CysLTR1, cysteinyl, damage, icardiac, Inhibitor, injury, leukotriene, Leukotriene Receptor, LeukotrieneReceptor, ischemia–reperfusion, Montelukast, intestinal, inhibit, liver, MK0476, MK-0476, MK 0476, Singular
Field of Research
Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:5 mg/mL (8.53 mM) ; H2O:1.7 mM; DMSO:250 mg/mL (426.49 mM)
Smiles
CC (C) (O) c1ccccc1CC[C@@H] (SCC1 (CC (O) =O) CC1) c1cccc (\C=C\c2ccc3ccc (Cl) cc3n2) c1
Molecular Formula
C35H36ClNO3S
Molecular Weight
586.18
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog